Scientists investigate a suspected culprit in the devastating muscle loss that weakens pancreatic cancer patients, with surprising findings about the PDK4 enzyme.
Exploring how genetic knockdown of ITCH E3 ubiquitin ligase increases pancreatic cancer cell sensitivity to therapeutics through advanced gene-editing techniques.
Discover how Histone Acetyltransferase 1 promotes gemcitabine resistance in pancreatic cancer through epigenetic regulation of the PVT1/EZH2 complex.
Discover how the loss of KDM5A epigenetic regulator accelerates KRAS-driven pancreatic cancer progression and impacts treatment strategies.
Explore how pancreatic adenocarcinoma hijacks the Ubiquitin-Proteasome System and the innovative research fighting back against this formidable cancer.
Groundbreaking research reveals how tumor-derived IGFBP-3 drives muscle wasting in pancreatic cancer patients through metabolic hijacking.